Impact of renin–angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study

OBJECTIVE: Association of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) use with coronavirus disease 2019 (COVID-19) remains controversial. We aimed to investigate the impact of ACEI/ARB use on all-cause mortality in severe COVID-19 patients with hypertension...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Yanjun, Zhao, Lishu, Wu, Guobao, Hu, Chunhong, Wu, Chenfang, Xu, Min, Dong, Haiyun, Zhang, Quan, Wang, Guyi, Yu, Bo, Lv, Jianlei, Wu, Chao, Zhang, Siye, Cao, Chenghui, Shu, Long, Pan, Yue, Liu, Xianling, Wu, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Special Issue: Coronavirus Outbreak: A Serious Public Health Issue
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745588/
https://www.ncbi.nlm.nih.gov/pubmed/33322988
http://dx.doi.org/10.1177/0300060520979151

Ejemplares similares

Ejemplares similares